Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2

被引:91
作者
Alkhateeb, A
Stetler, GL
Old, W
Talbert, J
Uhlhorn, C
Taylor, M
Fox, A
Miller, C
Dills, DG
Ridgway, EC
Bennett, DC
Fain, PR
Spritz, RA
机构
[1] Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA
[4] Univ London St Georges Hosp, Sch Med, Dept Anat & Dev Biol, London SW17 0RE, England
关键词
D O I
10.1093/hmg/11.6.661
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Generalized vitiligo is a common autoimmune disorder in which patchy loss of skin and hair pigmentation results from loss of pigment-forming melanocytes from the involved regions. Vitiligo occurs with a frequency of about 1% in most populations, and is highly associated with other autoimmune disorders, particularly Hashimoto thyroiditis. Most cases of vitiligo are sporadic, although some cases cluster in families, and the disorder is thought to be oligogenic in origin. We have studied a large family cluster in which vitiligo and Hashimoto thyroiditis occur in numerous individuals. A whole-genome scan of 24 family members, including 14 affected with autoimmune disease, showed significant linkage of an oligogenic autoimmune susceptibility locus, termed AIS1, to a 14.4 cM interval in 1p31.3-p32.2. A two-locus analysis of Hashimoto thyroiditis in family members segregating an AIS1 susceptibility allele showed suggestive linkage to markers in chromosome 6p22.3-q14.1, in a region spanning both the major histocompatibility complex and AITD1, a susceptibility locus for autoimmune thyroid disease. Our results indicate that the 1p AIS1 locus is associated with susceptibility to autoimmunity, particularly vitiligo, in this family, and that a chromosome 6 locus, most likely AITD1, may mediate the occurrence of Hashimoto's thyroiditis in AIS1-susceptible family members.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 37 条
  • [1] [Anonymous], 1933, INHERITED ABNORMALIT
  • [2] IMMUNOLOGICAL ASPECTS OF ENDOCRINE DISEASES
    BAKER, JR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (20): : 2899 - 2903
  • [3] Bhatia P. S., 1992, Journal of Dermatological Science, V4, P180, DOI 10.1016/0923-1811(92)90017-6
  • [4] The Colorado thyroid disease prevalence study
    Canaris, GJ
    Manowitz, NR
    Mayor, G
    Ridgway, EC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) : 526 - 534
  • [5] CARNEVALE A, 1980, REV INVEST CLIN, V32, P37
  • [6] HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective
    Chen, QY
    Huang, W
    She, JX
    Baxter, F
    Volpe, R
    Maclaren, NK
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) : 3182 - 3186
  • [7] The human leukocyte antigen HLA DRB3*0202/DQA1*0501 haplotype is associated with Graves' disease in African Americans
    Chen, QY
    Nadell, D
    Zhang, XY
    Kukreja, A
    Huang, YJ
    Wise, J
    Svec, F
    Richards, R
    Friday, KE
    Vargas, A
    Gomez, R
    Chalew, S
    Lan, MS
    Tomer, Y
    Maclaren, NK
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (04) : 1545 - 1549
  • [8] COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
  • [9] DAS S K, 1985, Genetic Epidemiology, V2, P255, DOI 10.1002/gepi.1370020303
  • [10] HAFEZ M, 1983, ACTA DERM-VENEREOL, V63, P249